We’ll start by passing on our most sincere gratitude to each and every individual and business who supported The Brunch 2021. It has been a challenging past 12 months for all, but the result of this event has shown us that it is times like these which really brings out the best in people.
On behalf of ABAL Banking and the George Khouzame Group, we’re proud to announce that our annual charity event for 2021 reached and exceeded our goal with over $140,000 raised for the Sydney Children’s Hospital Foundation (SCHF) and the Westmead Institute for Medical Research (WIMR).
At the commencement of our planning, SCHF approached us with either of the below two options to fundraise for:
- Ventilator with neonatal mode $50,039.83
To ensure adequate resuscitation equipment and support of patients requiring airway and ventilation support in the Emergency Department. This equipment provides frontline airway and ventilation support for critically ill medical, surgical and trauma patients, from the neonate to adolescent. Supports access to high level care for seriously ill patients. The machine supports time-critical diagnostic by being able to ventilate patients prior to imaging.
- Community Child Health Fellow $51,301.80
Fellows provide expert care for patients, whilst also increasing their skills in a specialised field. They help develop diagnosis methods, increase cure rates, reduce side effects of treatments and improve long-term outcomes. It’s not only today's patients who will benefit from the Fellowship Program but future generations of children around the world.
We’re proud to announce a total contribution of $101,341.63 has been made to the Sydney Children’s Hospitals Foundation which will allow for the purchase of both these wish list items.
In addition, we have been able to support the crucial work of WIMR. Particularly, Associate Professor Eddy Kizana – Co-Director of WIMR’s Centre for Heart Research, Head of WIMR’s Cardiac Gene Therapy Research Program.
Through his research, Associate Professor Eddy Kizana is discovering ways of using genes or genetic material to replace cardiac devices (like pacemakers or defibrillators). The ultimate goal of this critical research is to treat and prevent sudden death from common heart rhythm problems.
We’re pleased to announce a total contribution of $40,000.00 to this research program.
Neither the funds raised, nor the day itself could have been possible without the support of our partners, corporate table sponsors, gift donors and attendees on the day.
We’ll take this opportunity to recognise the support of our Corporate Event Partner, KOL Group and our Fundraising Partners, Madison Marcus and ETHAN. Your trust and unwavering support has allowed us to reach this outcome.
Once again, thank you to all our dear colleagues and friends. Keep safe and well.
Enjoy the gallery of images from the day below, and keep up to date with our ongoing initiatives via our Instagram page @abablbanking.
